Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; lactose monohydrate; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; croscarmellose sodium; hypromellose; colloidal anhydrous silica; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; hypromellose; lactose monohydrate; microcrystalline cellulose; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; croscarmellose sodium; magnesium stearate; lactose monohydrate; colloidal anhydrous silica; titanium dioxide; macrogol 4000 - - indicated for the treatment of hypertension.,- indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: hypromellose; iron oxide black; macrogol 6000; colloidal anhydrous silica; lactose monohydrate; titanium dioxide; croscarmellose sodium; purified talc; microcrystalline cellulose; hyprolose; iron oxide red; magnesium stearate - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; lactose monohydrate; hyprolose; titanium dioxide; croscarmellose sodium; colloidal anhydrous silica; macrogol 6000; purified talc; microcrystalline cellulose; iron oxide red; iron oxide yellow - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Malta - English - Medicines Authority

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - irbesartan - film-coated tablet - irbesartan 75 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - irbesartan - film-coated tablet - irbesartan 150 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - irbesartan - film-coated tablet - irbesartan 300 mg - agents acting on the renin-angiotensin system